IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, Y.
Right arrow Articles by Kato, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, Y.
Right arrow Articles by Kato, S.

Investigative Ophthalmology & Visual Science, Vol 31, 411-418, Copyright © 1990 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Herpes simplex virus glycoprotein D. Protective immunity against murine herpetic keratitis

Y Inoue, Y Ohashi, Y Shimomura, R Manabe, M Yamada, S Ueda and S Kato
Department of Ophthalmology, Osaka University Medical School, Japan.

%$%%protective effect of glycoprotein D (gD) immunization against murine herpetic keratitis was investigated. gD was purified by affinity chromatography using anti-gD monoclonal antibodies. Prior immunization with gD was shown to be effective in protecting mice from both the development of stromal keratitis and the spread of the virus to the central nervous system. The level of serum antibodies for virus neutralization, as well as for complement-dependent cytolysis (CDC), was significantly elevated in gD-immunized animals. Cellular immunity, however, was not detected. These results indicate that two antibody- mediated defense mechanisms--virus neutralization and CDC--were responsible for the protective effect observed in our study.


This article has been cited by other articles:


Home page
 CVIHome page
E. Konishi, Y. Kitai, and T. Kondo
Utilization of Complement-Dependent Cytotoxicity To Measure Low Levels of Antibodies: Application to Nonstructural Protein 1 in a Model of Japanese Encephalitis Virus
Clin. Vaccine Immunol., January 1, 2008; 15(1): 88 - 94.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
T. Murata, F. Goshima, H. Takakuwa, and Y. Nishiyama
Excretion of herpes simplex virus type 2 glycoprotein D into the culture medium
J. Gen. Virol., November 1, 2002; 83(11): 2791 - 2795.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Thakur, J. Kyd, M. Xue, M. D. P. Willcox, and A. Cripps
Effector Mechanisms of Protection against Pseudomonas aeruginosa Keratitis in Immunized Rats
Infect. Immun., May 1, 2001; 69(5): 3295 - 3304.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Inoue, Y. Inoue, T. Nakamura, A. Yoshida, K. Takahashi, Y. Inoue, Y. Shimomura, Y. Tano, Y. Fujisawa, A. Aono, et al.
Preventive Effect of Local Plasmid DNA Vaccine Encoding gD or gD-IL-2 on Herpetic Keratitis
Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4209 - 4215.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the Association for Research in Vision and Ophthalmology